1Turner ST, Jack CR, Fornage M, et al. Heritability ot leukoaraiosis in hypertensive sibships. Hypertension, 2004, 43: 483-487.
2Bocti C, Swartz RH, Gao FQ, et al. A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia. Stroke, 2005,36:2126-2131.
3Tarvonen Schroder S,Roytta M, Ralha I, et al. Clinical features of leukoaraiosis. J Neuro Neurosurg Psychiatry 1996,60 : 431-436.
4Kawamura J, Meyer JS, Terayama Y, et al. Leukoaraiosis correlates with cerebral hypopcrfusion in vascular dementia. Stroke, 1991, 22 : 609-614.
5Meyer JS, Rauch GM, Rauch RA, et al. Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia. Ann N Y Acad Sci, 2000, 903:411-423.
6Bamford J, Sandercoek P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet, 1991, 337:1521-1526.
7Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet, 1974, 2:81-84.
8Matsushita K, Kuriyama Y, Nagatsuka K, ct al. Periventricular white matter lucency and cerebral blood flow autoregulation in hypertensive patients. Hypertension, 1994, 23:565-568.
9Marstrand JR,Garde E, Rostrup E, et al. Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke, 2002, 33:972-976.
